Danaparoid for heparin-induced thrombocytopenia: an analysis of treatment failures.


BACKGROUND Patients with heparin-induced thrombocytopenia (HIT) (with or without thrombosis) require alternative anticoagulation because of their extreme risk of new thromboembolic complications. The first effective agent for this purpose may be danaparoid, a less-sulfated low molecular weight heparinoid. Recently, direct thrombin inhibitors have been used… (More)


  • Presentations referencing similar topics